These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7489832)

  • 1. The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats.
    Rösen R; Rump AF; Rösen P
    Diabetologia; 1995 May; 38(5):509-17. PubMed ID: 7489832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats.
    Rösen P; Rump AF; Rösen R
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):64-70. PubMed ID: 8656660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.
    Al-Shafei AI; Wise RG; Gresham GA; Carpenter TA; Hall LD; Huang CL
    J Physiol; 2002 Jan; 538(Pt 2):555-72. PubMed ID: 11790819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat.
    Brooks WW; Bing OH; Robinson KG; Slawsky MT; Chaletsky DM; Conrad CH
    Circulation; 1997 Dec; 96(11):4002-10. PubMed ID: 9403625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
    Takeda H; Haneda T; Kikuchi K
    Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac dysfunction in the euglycemic diabetic-prone BB Wor rat.
    Broderick TL; Hutchison AK
    Metabolism; 2004 Nov; 53(11):1391-4. PubMed ID: 15536590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.
    Al-Shafei AI; Wise RG; Gresham GA; Bronns G; Carpenter TA; Hall LD; Huang CL
    J Physiol; 2002 Jan; 538(Pt 2):541-53. PubMed ID: 11790818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of angiotensin I and angiotensin II: dose-response studies in the isolated perfused rat heart.
    Traquandi C; Riva E
    Pharmacol Res; 1998 Jan; 37(1):57-65. PubMed ID: 9503481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
    Benter IF; Yousif MH; Al-Saleh FM; Raghupathy R; Chappell MC; Diz DI
    J Cardiovasc Pharmacol; 2011 May; 57(5):559-67. PubMed ID: 21326110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.
    van Wijngaarden J; Monnink SH; Bartels H; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    J Cardiovasc Pharmacol; 1992 May; 19(5):741-7. PubMed ID: 1381772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of glycosylated hemoglobin to in vivo cardiac function in response to dobutamine in spontaneously diabetic BB Wor rats.
    Broderick TL; Kopp SJ; Daar JT; Romano FD; Paulson DJ
    Can J Physiol Pharmacol; 1994 Jul; 72(7):722-37. PubMed ID: 7828080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors: a new mechanism of action.
    Peng H; Carretero OA; Vuljaj N; Liao TD; Motivala A; Peterson EL; Rhaleb NE
    Circulation; 2005 Oct; 112(16):2436-45. PubMed ID: 16216963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of left ventricular relaxation in the isolated heart by an angiotensin-converting enzyme inhibitor.
    Anning PB; Grocott-Mason RM; Lewis MJ; Shah AM
    Circulation; 1995 Nov; 92(9):2660-5. PubMed ID: 7586370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE (Angiotensin-Converting Enzyme) Inhibition Reverses Vasoconstriction and Impaired Dilation of Pial Collaterals in Chronic Hypertension.
    Li Z; Lindner DP; Bishop NM; Cipolla MJ
    Hypertension; 2020 Jul; 76(1):226-235. PubMed ID: 32418498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction.
    Jin H; Yang R; Awad TA; Wang F; Li W; Williams SP; Ogasawara A; Shimada B; Williams PM; de Feo G; Paoni NF
    Circulation; 2001 Feb; 103(5):736-42. PubMed ID: 11156887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.
    Mitręga KA; Spałek AM; Nożyński J; Porc M; Stankiewicz M; Krzemiński TF
    PLoS One; 2017; 12(6):e0179633. PubMed ID: 28636634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats.
    Capasso JM; Li P; Meggs LG; Herman MV; Anversa P
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):584-93. PubMed ID: 7516008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.